LDA analysis for Study ST003260

(Analysis AN005344 )

Select 3 or more experimental factors for PCA analysis.
GroupExperimental factor
Sample source:Breast cancer cells | Treatment:10 µM Comp. 1 | time point:2 h
Sample source:Breast cancer cells | Treatment:10 µM Comp. 2 | time point:2 h
Sample source:Breast cancer cells | Treatment:10 µM Comp. 3 | time point:2 h
Sample source:Breast cancer cells | Treatment:10 µM RSL3 | time point:24 h
Sample source:Breast cancer cells | Treatment:10 µM RSL3 | time point:2 h
Sample source:Breast cancer cells | Treatment:10 µM RSL3 | time point:4 h
Sample source:Breast cancer cells | Treatment:10 µM RSL3 | time point:6 h
Sample source:Breast cancer cells | Treatment:1 µM Comp. 1 | time point:2 h
Sample source:Breast cancer cells | Treatment:1 µM Comp. 2 | time point:2 h
Sample source:Breast cancer cells | Treatment:1 µM Comp. 3 | time point:2 h
Sample source:Breast cancer cells | Treatment:1 µM RSL3 + 3 µM Ferrostatin | time point:2 h
Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:24 h
Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:2 h
Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:4 h
Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:6 h
Sample source:Breast cancer cells | Treatment:3 µM Comp. 1 | time point:2 h
Sample source:Breast cancer cells | Treatment:3 µM Comp. 2 | time point:2 h
Sample source:Breast cancer cells | Treatment:3 µM Comp. 3 | time point:2 h
Sample source:Breast cancer cells | Treatment:DMSO | time point:24 h
Sample source:Breast cancer cells | Treatment:DMSO | time point:2 h
Sample source:Breast cancer cells | Treatment:DMSO | time point:4 h
Sample source:Breast cancer cells | Treatment:DMSO | time point:6 h

OR

Perform LDA on individual factors (all analyses in study)
  logo